Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)
Phase 4
Terminated
- Conditions
- HivNeurocognitive Dysfunction
- Interventions
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Giovanni Di Perri
- Target Recruit Count
- 38
- Registration Number
- NCT03163277
- Locations
- 🇮🇹
University of Torino, Torino, Italy
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
Phase 4
Terminated
- Conditions
- HIV InfectionOsteopenia
- Interventions
- Drug: tenofovir/emtricitabine and atazanavir and ritonavir
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Giovanni Di Perri
- Target Recruit Count
- 4
- Registration Number
- NCT01902186
- Locations
- 🇮🇹
University of Milano, Milano, Italy
🇮🇹University of Torino, Torino, Italy
Early- and Late-onset Candidemia
Completed
- Conditions
- Candidemia
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Giovanni Di Perri
- Target Recruit Count
- 400
- Registration Number
- NCT01406093
- Locations
- 🇮🇹
Hospital San Giovanni Battista - Molinette, Torino, Italy
News
No news found